In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…
Read More
Biogen Acquires Apellis Pharmaceuticals for $5.6 Billion to Bolster Immunology and Rare Disease Portfolio
Biogen, a global biotechnology company renowned for its pioneering work in neuroscience, has announced a significant strategic acquisition of Apellis…
Read More
Rocket Pharmaceuticals Secures Landmark FDA Approval for Kresladi, Ushering in a New Era for Ultra-Rare Immune Disease Treatment
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rocket Pharmaceuticals’ Kresladi (marnetegragene autotemcel), a groundbreaking gene…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Driven by Fusion Gene Liquid Droplets
In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…
Read More
A Rare Lunar Impact Creates a Crater the Size of Two Football Fields
The moon, a silent sentinel in our night sky, has revealed a dramatic new feature: a fresh impact crater, estimated…
Read More
New drug cuts seizures by up to 91% in children with rare epilepsy
In a landmark development for pediatric neurology, an international clinical trial has demonstrated that an experimental genetic therapy, zorevunersen, can…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Progression via Liquid Condensates
In a significant advancement for the field of molecular oncology, a collaborative study led by investigators at the Johns Hopkins…
Read More
